Xavier C Badoux

2PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 13, 2023
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.

Nitin Jain, Lisa J Croner, John N Allan

|Jun 07, 2023
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.

John N Allan, Ian W Flinn, Tanya Siddiqi

Pageof 1

Frequent Collaborators

2 joint publications

John N Allan

2 joint publications

Tanya Siddiqi

2 joint publications

Alessandra Tedeschi

1 joint publications

Ian W Flinn